Backed by Science, Built for Translation

Editpep holds the exclusive global therapeutic license from UC Berkeley for the PERC™ platform, based on breakthrough work from the Wilson lab at the Innovative Genomics Institute. We are actively advancing toward preclinical development of CNS‑targeted CRISPR therapies.

We’re on a mission to unlock CRISPR’s potential to treat brain diseases through a scalable, safe, and precise delivery platform.

Editpep was founded in 2023 by Dana Foss, PhD, and Ross Wilson, PhD, as a spinout from UC Berkeley and the Innovative Genomics Institute. What began as a breakthrough in academic labs is now being built into a therapeutic reality, with a team focused on translating delivery science into real clinical impact.

Our goal is simple: to bring life-changing genome editing therapies to patients with devastating neurological diseases, starting with those who currently have no effective options.

Headquartered at Bakar BioLabs in Berkeley, CA, we’re proud to be part of the Bay Area’s leading biotech startup community, connected to world-class research, talent, and infrastructure.

Expert‑Led, Mission‑Driven Team

We are scientists, strategists, and builders, grounded in gene editing, neuroscience, and translational drug development.

Dana Foss, PhD

CEO & Co-founder

Co-inventor of PERC™, expert in gene therapy delivery

Jake Lesnik

Chief Business Officer

Business development leader in cell and gene therapy

Piotr Hadaczek, PhD

VP of Translational Neuroscience

Co-developer of Editpep platform, 20+ years in CNS gene therapy

Francesca Manea, PhD

Expertise in protein chemistry & characterization & biochemical/ biophysical method development

Senior Scientist – Platform Biochemistry

Raniel Alcantara-Lee

Associate Scientist

15+ years of industry experience running pre-clinical in vivo studies

Benjamin Gowen, PhD

Director of Biology

CRISPR delivery expert, formerly at Spotlight Therapeutics

Co-Founders and Advisors

Ross Wilson, PhD

Founder & Advisor

Assistant Adjunct Professor, UC Berkeley; Director of Therapeutic Delivery at IGI

Krys Bankiewicz, MD, PhD

Practicing neurosurgeon, pioneer in administering gene therapies to the brain. Prof. of Neurological Surgery & Vice Chair of Research at OSUCM.

Editpep Co-founder, Advisor, Investor

Get in Touch

Whether you’re interested in collaboration, licensing, or joining the journey as we translate CRISPR therapies into the clinic, we’d love to connect.